Anthem launches patient-provider interface app with Samsung, American Well

Anthem announced a partnership with Samsung and American Well to offer a mobile app that will connect patients with U.S.-based healthcare providers for non-emergency medical information. The “Experts” service will be available the Anthem-covered individuals with Samsung mobile devices.

“Anthem’s partnership with Samsung and American Well is one way we are investing in innovation and digital capabilities that will advance access to healthcare for consumers across the country,” said Peter D. Haytaian, Executive Vice President and President, Commercial and Specialty Business Division, Anthem. “At Anthem, we are leveraging the power of technology, challenging the status quo and collaborating with leaders across industries, to create a simpler, more affordable, and accessible healthcare system. The healthcare needs of consumers are incredibly dynamic, and technology will continue to be the gateway to enable consumers broader choice of care to improve their health and well-being.”

Users can video chat with providers for issues such as the flu, allergies, coughs and colds. According to an Anthem release, providers can diagnose conditions and issue prescriptions. Individuals can also consult specialists in various areas, including nutrition and dermatology.

“Our goal with Samsung Health’s ‘Experts’ service is to provide users with ubiquitous access to leading healthcare providers and insurers quickly and cost effectively, right from the palm of their hands,” said Nana Murugesan, vice president and general manager at Samsung Electronics America. “When we launched Experts just one year ago, our users were mostly using the service for everyday illnesses like the colds and coughs. Now our users are increasingly using the service for more advanced telehealth treatments such as the flu, high blood pressure and insomnia, as we expand our relationships with leaders in the healthcare industry. We are pleased to work with Anthem and welcome the LiveHealth Online service into the fold with American Well for Samsung Health."

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.